Recombinant Mouse LRPAP1 Protein, N-His from ProteoGenix; catalogue ARO-P11037; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Mouse LRPAP1 Protein, also known as low-density lipoprotein receptor-related protein-associated protein 1, is a key protein involved in the regulation of lipid metabolism and cellular signaling pathways. This protein is produced through recombinant technology, making it highly pure and suitable for various research applications. In this article, we will discuss the structure, activity, and applications of Recombinant Mouse LRPAP1 Protein.
Recombinant Mouse LRPAP1 Protein is a 37 kDa protein consisting of 334 amino acids. It is composed of three domains: an N-terminal domain, a central domain, and a C-terminal domain. The N-terminal domain is responsible for binding to other proteins, while the central domain contains a conserved cysteine-rich region that is essential for protein-protein interactions. The C-terminal domain is involved in the regulation of LRP1-mediated endocytosis.
Recombinant Mouse LRPAP1 Protein plays a crucial role in the regulation of lipid metabolism and cellular signaling pathways. It acts as a chaperone protein, binding to and stabilizing the low-density lipoprotein receptor-related protein 1 (LRP1). LRP1 is a multifunctional cell surface receptor that is involved in the clearance of lipoproteins, cellular signaling, and endocytosis. Recombinant Mouse LRPAP1 Protein also interacts with other proteins, such as apolipoprotein E (apoE), to regulate their functions.
One of the key activities of Recombinant Mouse LRPAP1 Protein is its role in the regulation of cholesterol homeostasis. It binds to LRP1 and facilitates the clearance of cholesterol from the bloodstream by promoting its uptake into cells. This activity is essential for maintaining healthy cholesterol levels and preventing the development of cardiovascular diseases.
Moreover, Recombinant Mouse LRPAP1 Protein has been shown to modulate cellular signaling pathways. It interacts with LRP1 to regulate the activation of several signaling molecules, including the mitogen-activated protein kinase (MAPK) pathway. This pathway is involved in cell proliferation, differentiation, and survival, and its dysregulation has been linked to various diseases, such as cancer. Therefore, Recombinant Mouse LRPAP1 Protein may have potential applications in the treatment of these diseases by modulating the MAPK pathway.
Recombinant Mouse LRPAP1 Protein has a wide range of applications in biomedical research. It can be used as an antigen for the production of specific antibodies to study the function and regulation of LRP1. These antibodies can be used in various techniques, including Western blotting, immunoprecipitation, and immunofluorescence, to detect and quantify the expression of LRPAP1 in different tissues and cell types.
Furthermore, Recombinant Mouse LRPAP1 Protein can be used in in vitro and in vivo studies to investigate its role in cholesterol metabolism and cellular signaling pathways. It can be added to cell culture media to study its effects on cellular processes, such as cholesterol uptake and cellular signaling. In animal studies, Recombinant Mouse LRPAP1 Protein can be administered to investigate its potential therapeutic effects on diseases related to cholesterol metabolism and cellular signaling.
In addition, Recombinant Mouse LRPAP1 Protein has potential applications in drug discovery and development. Its role in regulating cholesterol levels and cellular signaling makes it an attractive target for the development of novel therapeutics. By modulating the activity of LRP1 and other signaling pathways, Recombinant Mouse LRPAP1 Protein may have potential applications in the treatment of various diseases, including cardiovascular diseases and cancer.
In summary, Recombinant Mouse LRPAP1 Protein is a key protein involved in the regulation of lipid metabolism and cellular signaling pathways. Its structure, activity, and potential applications make it
ProteoGenix catalogue number ARO-P11037. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 27.55 kDa; Fragment: Glu148-Leu360; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
